Early use of clozapine for poorly responding first-episode psychosis

Journal of Clinical Psychopharmacology

Volumn 27, Issue 4, 2007, Pages 369-373

  Agid, Ofer ^a,b   Remington, Gary ^a,b   Kapur, Shitij ^a,b   Arenovich, Tamara ^b,c   Zipursky, Robert B ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; OLANZAPINE; QUETIAPINE; RISPERIDONE;

ADOLESCENT; ADULT; ALGORITHM; ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; PSYCHOSIS; RATING SCALE; THERAPY EFFECT; TREATMENT REFUSAL; TREATMENT RESPONSE;

ADOLESCENT; ADULT; ALGORITHMS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CLOZAPINE; DIBENZOTHIAZEPINES; DRUG RESISTANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; RISPERIDONE; SCHIZOPHRENIA;

EID: 34447521700     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/jcp.0b013e3180d0a6d4     Document Type: Article

References (24)

1. Group TSSR. The Scottish First Episode Schizophrenia Study V. One-year follow-up. The Scottish Schizophrenia Research Group. Br J Psychiatry. 1988;152:470-476.
2. Lieberman J, Jody D, Geisler S, et al. Time course and biologic correlates of treatment response in first-episode schizophrenia. Arch Gen Psychiatry. 1993;50(5):369-376.
3. Kopala LC, Fredrikson D, Good KP, et al. Symptoms in neuroleptic-naive, first-episode schizophrenia: response to risperidone. Biol Psychiatry. 1996;39(4):296-298.
4. McCreadie RG. Managing the first episode of schizophrenia: the role of new therapies. Eur Neuropsychopharmacol. 1996;6(suppl 2):S3-S5.
5. Robinson DG, Woerner MG, Alvir JM, et al. Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder. Am J Psychiatry. 1999;156(4):544-549.
6. Davis JM, Schaffer CB, Killian GA, et al. Important issues in the drug treatment of schizophrenia. Schizophr Bull. 1980;6(1):70-87.
7. Manchanda R, Norman RM, Malla AK, et al. Persistent psychoses in first episode patients. Schizophr Res. 2005;80(1):113-116.
8. Kane J, Honigfeld G, Singer J, et al. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry. 1988;45(9):789-796.
9. Juul Povlsen U, Noring U, Fog R, et al. Tolerability and therapeutic effect of clozapine. A retrospective investigation of 216 patients treated with clozapine for up to 12 years. Acta Psychiatr Scand. 1985;71(2):176-185.
10. Kane JM. Clinical efficacy of clozapine in treatment-refractory schizophrenia: an overview. Br J Psychiatry Suppl. 1992;160(suppl 17):41-45.
11. Leon CA. Therapeutic effects of clozapine. A 4-year follow-up of a controlled clinical trial. Acta Psychiatr Scand. 1979;59(5):471-480.
12. Meltzer HY, Bastani B, Kwon KY, et al. A prospective study of clozapine in treatment-resistant schizophrenic patients. I. Preliminary report. Psychopharmacology (Berl). 1989;99(suppl):S68-S72.
13. Rosenheck R, Cramer J, Xu W, et al. A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. N Engl J Med. 1997;337(12):809-815.
14. Small JG, Milstein V, Marhenke JD, et al. Treatment outcome with clozapine in tardive dyskinesia, neuroleptic sensitivity, and treatment-resistant psychosis. J Clin Psychiatry. 1987;48(7):263-267.
15. Kane JM, Marder SR, Schooler NR, et al. Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison. Arch Gen Psychiatry. 2001;58(10):965-972.
16. Lewis SBT, Murray R, Davies L, et al. First generation versus second generation (non-clozapine) antipsychotic drugs versus clozapine in schizophrenia: the CUtLASS trials. Neuropsychopharmacology. 2005;30(suppl 1):S31-S32.
17. McEvoy JP, Lieberman JA, Stroup TS, et al. Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. Am J Psychiatry. 2006;163(4):600-610.
18. Lieberman JA, Phillips M, Gu H, et al. Atypical and conventional antipsychotic drugs in treatment-naive first-episode schizophrenia: a 52-week randomized trial of clozapine vs chlorpromazine. Neuropsychopharmacology. 2003;28(5):995-1003.
19. Woerner MG, Robinson DG, Alvir JM, et al. Clozapine as a first treatment for schizophrenia. Am J Psychiatry. 2003;160(8):1514-1516.
20. Szymanski S, Masiar S, Mayerhoff D, et al. Clozapine response in treatment-refractory first-episode schizophrenia. Biol Psychiatry. 1994;35(4):278-280.
21. Guy W. Clinical Global Impression. Rockville, MD: U.S. Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs; 1976.
22. Overall JEG. The Brief Psychiatric Rating Scale. Psychol Rep. 1962;10:799-812.
23. Agid O, Kapur S, Arenovich T, et al. Delayed-onset hypothesis of antipsychotic action: a hypothesis tested and rejected. Arch Gen Psychiatry. 2003;60(12):1228-1235.
24. Kapur S, Arenovich T, Agid O, et al. Evidence for onset of antipsychotic effects within the first 24 hours of treatment. Am J Psychiatry. 2005;162(5):939-946.